Nanobiotix S.A. (0QAV.L) LSE

19.64

-0.3(-1.50%)

Updated at December 24 11:56AM

Currency In EUR

Valuation

Market Cap141.8M
Enterprise Value142.96M
P/E Ratio-13.68
PEG Ratio0.16
Price/Sales Ratio-81.86
Price/Book Ratio-14.19
Enterprise/Revenue-81.96
Enterprise/EBITDA-14.06

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin5.87
Operating Margin5.89

Management Effectiveness

Return On Assets-1.01
Return On Equity1.56

Income Statement

Revenue-11.61M
Revenue/Share-0.25
Gross Profit0
EBITDA-61.62M
Net Income-68.13M
Diluted EPS-1.44

Balance Sheet

Total Cash28.82M
Total Cash/Share1.05
Total Debt51.24M
Total Debt/Equity-0.77
Current Ratio1.04
Book Value Per Share-1.39

Price History

52-Week Change546.05
52-Week High19.9
52-Week Low1.62
Moving Average 50 Days6.68
Moving Average 200 Days6.55

Statistics

Average Volume8,588
Shares Outstanding48.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A